These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Antinuclear factor in lupus erythematosus. Ervanian A J Iowa Med Soc; 1972 Oct; 62(10):545 passim. PubMed ID: 4116364 [No Abstract] [Full Text] [Related]
5. [Current significance of the LE-phenomenon and antinuclear seroreactions in clinical diagnosis]. Beickert A Z Arztl Fortbild (Jena); 1973 Jan; 67(2):75-9. PubMed ID: 4121746 [No Abstract] [Full Text] [Related]
7. [Antinuclear factors. Clinical and humoral correlations; diagnostic importance]. Purice S; Gheorghiu M; Ghelerter L; Drăgoi T Med Interna (Bucur); 1969 Oct; 21(10):1205-40. PubMed ID: 4189145 [No Abstract] [Full Text] [Related]
8. [Immunopathological studies of intradermal tests with DNA in lupus erythematosus]. Wranicz A Przegl Dermatol; 1972; 59(2):183-8. PubMed ID: 4537151 [No Abstract] [Full Text] [Related]
9. [Analysis of antinuclear antibodies by fluorescent antibody technic using tissue culture cells]. Onodera S; Shibata A; Miura A; Suzuki A; Sakamoto S Saishin Igaku; 1969 May; 24(5):1113-7. PubMed ID: 4185953 [No Abstract] [Full Text] [Related]
10. [Characteristics of clinical course and immunology of systemic lupus erythematosus (SLE) in males]. Zhuravlev GI; Rodshteĭn OA Sov Med; 1974 Jul; 0(7):99-103. PubMed ID: 4137379 [No Abstract] [Full Text] [Related]
11. [Determination of antinuclear antibodies, anti-DNA antibodies, C 3 complement factor and IgG in lupus erythematosus and rheumatoid arthritis]. Lehmann C; Hurtado R; Valdivieso M; Godoy G; Sorensen R Rev Med Chil; 1972; 100(5):485-9. PubMed ID: 4114175 [No Abstract] [Full Text] [Related]
12. [Blastic lymphocyte transformation in lupus erythematosus and scleroderma]. Pawińska M; Gliński W; Blaszczyk M; Wranicz A Przegl Dermatol; 1973; 60(2):161-6. PubMed ID: 4134109 [No Abstract] [Full Text] [Related]
13. [Significance of DNAase activity of blood in systemic lupus erythematosus]. Klimov VIu Sov Med; 1974 Nov; (11):78-81. PubMed ID: 4280140 [No Abstract] [Full Text] [Related]
14. [Significance of antinuclear antibodies for the diagnosis and activity of systemic lupus erythematosus]. Xie H; Liu Z; Zhu W Hunan Yi Ke Da Xue Xue Bao; 1997; 22(2):177-8. PubMed ID: 9868068 [No Abstract] [Full Text] [Related]
15. [Antinuclear antibodies and beta1A concentration in systemic lupus erythematosus and other diseases]. Monegat JN; Joller-Jemelka HI; Grob PJ Schweiz Med Wochenschr; 1974 Nov; 104(45):1614-23. PubMed ID: 4612703 [No Abstract] [Full Text] [Related]
16. [Correlation between the presence of antibodies to native DNA and the occurrence of the LE phenomenon in patients with visceral lupus erythematosus]. Marczak M; Kardaszewicz E; Sikora M Pol Tyg Lek; 1982 May; 37(12):339-40. PubMed ID: 6182556 [No Abstract] [Full Text] [Related]
17. [Significance of antinuclear antibodies in overlap syndromes. I. Relationship between systemic lupus erythematosus, diffuse scleroderma and dermatomyositis]. Zitnan D; Rovenský J; Cebecauer L; Hajzok O Fysiatr Revmatol Vestn; 1973 Jun; 51(3):152-7. PubMed ID: 4592583 [No Abstract] [Full Text] [Related]
18. [Influence of cytostatic drugs on antinuclear antibodies in visceral lupus erythematosus]. Mantel W; Holtz G Z Rheumatol; 1974; 33(7-8):241-8. PubMed ID: 4139839 [No Abstract] [Full Text] [Related]
19. Clinical and theoretical interest of the immunochemical analysis of antinuclear antibodies in systemic lupus erythematosus. Tron F; Jacob L; Bach JF Adv Nephrol Necker Hosp; 1983; 12():215-37. PubMed ID: 6188347 [No Abstract] [Full Text] [Related]